IRCMS, Kumamoto University

What IRCMS, Kumamoto University does

IRCMS (International Research Center for Medical Sciences) is an academic research center established in 2015 and embedded within Kumamoto University on the Honjo-Kuhonji Campus in Kumamoto City, Japan. It operates under Kumamoto University's governance as a government state entity and is structured around seven Principal Investigators and their respective labs, with English as the official language for seminars and lab meetings and an open laboratory layout designed to minimize physical and disciplinary boundaries between research groups. The center concentrates on four core research fields — stem cells, cancer, development, and aging — spanning subdomains such as stem cell stress hematopoiesis, hematopoietic stem cell engineering, developmental cardiology and morphogenesis, multicellular dynamics, proteostasis in stem cells, multi-dimensional imaging, chromatin organization in immune cell development, epigenetic inheritance, and transcriptional regulation in leukemogenesis. Approximately 40% of current resident researchers are international, and the center runs dedicated internship and fellowship programs for international students in addition to recurring IRCMS and D5 Medical & Life Science Seminars and an annual symposium series.

IRCMS does not sell commercial products or services and does not operate a pricing model. It is funded through Japanese government programs — including the Japan Society for the Promotion of Science (JSPS), Japan Science and Technology Agency (JST), and Kumamoto University allocations — together with competitive research grants such as the JSPS Core-to-Core Program. The center sustains an international collaboration network with Lund University (Sweden), Imperial College London (UK), the Institute of Medical Science at the University of Tokyo (IMSUT), KAIST (Korea), National Taiwan University, and Mahidol University (Thailand), and in April 2024 jointly established the Laboratory of Hematopoietic Stem Cell Engineering with the Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN), accompanied by a Cross-Appointment Agreement for the lab's principal investigator. Its go-to-market is event-driven and academic: dissemination occurs through peer-reviewed publications, seminars, symposiums, research internships and fellowships, and social media channels rather than through commercial channels, and its 'customers' are the academic research community, international graduate students, and collaborative institutions rather than paying buyers.

The center's competitive position rests on the talent density of its PI cohort, its co-location with Kumamoto University Hospital and adjacent institutes (IRDA, IMEG, Joint Research Center for Human Retroviruses), and a steady publication and award record in 2024, including a JSDB Frontiers Prize, a Young Investigator Award, a Best Poster Award, a Science Pitch Award, a Best Presentation Award, and a Japanese Society of Hematology Encouragement Award. At the same time, the center is small (approximately seven PIs), has no commercial revenue, operates under single-jurisdiction Japanese state funding, and has experienced notable senior PI departures (Prof. Goro Sashida to Tokyo Metropolitan Institute of Medical Science; Prof. Takatsugu Ishimoto to the Cancer Institute, Japanese Foundation for Cancer Research), which is normal academic mobility but a relevant consideration for institutional continuity.

Name

IRCMS, Kumamoto University

Legal name

International Research Center for Medical Sciences (IRCMS)

Website

https://ircms.kumamoto-u.ac.jp

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

IRCMS is an academic research center at Kumamoto University, established 2015, operating seven PI-led labs focused on stem cells, cancer, development, and aging. It is publicly funded, hosts international researchers and interns, and sustains global collaborations with Lund, Imperial College London, KAIST, and others.

Ownership category

akta.pro rank

Headquarters

HQ city

Kumamoto

HQ country

Japan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Research Funding: Supported by Japanese government programs including Japan Society for the Promotion of Science (JSPS), Japan Science and Technology Agency (JST), and university allocations. Also receives funding through competitive research grants and the Core-to-Core Program.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

IRCMS is an academic research center at Kumamoto University that conducts fundamental life sciences research focused on stem cells, hematopoiesis, cancer, developmental biology, and aging. It also provides research internship and fellowship programs for international students and postdoctoral researchers, and facilitates research collaboration through JSPS Core-to-Core Program partnerships with international institutions.

Product overview

IRCMS (International Research Center for Medical Sciences) is an academic research institution at Kumamoto University established in 2015. It is not a product company but rather a research center that provides educational programs, seminars, symposiums, and research opportunities. The center operates open laboratories with 7 principal investigators and their research labs focusing on stem cells, cancer, development, and aging research. It offers the IRCMS Research Internship Program for international students and conducts regular seminars and symposiums for the research community.

Differentiator

Problem solved

Functional benefit

Products and services

• IRCMS Research Internship Program A research internship program for international students to conduct research at IRCMS, Kumamoto University, providing hands-on laboratory experience in medical sciences.
• IRCMS Fellowship Program Fellowship program offering research positions for graduate students and postdoctoral researchers at IRCMS.
• D5 Medical & Life Science Seminar Monthly seminar course covering topics in medical and life sciences including physiological functions, pathophysiology, stem cell biology, and disease mechanisms.
• JSPS Core-to-Core Program - Integrative approach for normal and leukemic stem cells International research collaboration program focused on stem cell research, integrating approaches for normal and leukemic stem cells with partner institutions including Imperial College London and Lund University.

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Eight partnerships are on record, tiered core and major.

• The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)coreStrategic or Co-development Partner · 1 April 2024Joint establishment of Laboratory of Hematopoietic Stem Cell Engineering at IRCMS on April 1, 2024. Focuses on mechanisms of self-renewal divisions for stem cell expansion in hematopoietic stem cells and development of stem cell-based therapies.
• Institute of Medical Science, The University of Tokyo (IMSUT)majorStrategic or Co-development Partner · 13 February 2024Joint JSPS Core-to-Core Program Mini Symposium on 'Pathogenesis and therapeutic targeting of hematological malignancies'. Collaborative research in leukemia and hematological disorders.
• Lund UniversitycoreStrategic or Co-development Partner · 1 January 2020Active collaboration through JSPS Core-to-Core Program 'Integrative approach for normal and leukemic stem cells'. Regular joint symposiums held including Lund-Kumamoto Hematopoiesis Meeting. Includes researcher exchanges and collaborative research in stem cell and hematopoiesis fields.
• Imperial College LondoncoreStrategic or Co-development Partner · 1 January 2020Collaboration through JSPS Core-to-Core Program on integrative approaches for normal and leukemic stem cells. Joint Retrovirology Symposium held. Includes researcher exchanges and collaborative seminars.
• Japan Society for the Promotion of Science (JSPS)coreOthersSupports international research visits through Core-to-Core Program, overseas fellowship programs, and research exchange activities for IRCMS members.
• Japan Science and Technology Agency (JST)majorOthersProvides funding and support for international research programs and researcher exchanges.
• KAIST (Korea Advanced Institute of Science and Technology)majorStrategic or Co-development PartnerJoint symposiums conducted including The 6th KU-KAIST Joint Symposium for Medical Science and Engineering. Collaborative research exchanges in biomedical sciences.
• National Taiwan UniversitymajorStrategic or Co-development PartnerJoint symposium on biomedical research conducted. Collaborative exchanges in medical and life sciences.

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Stanford Institute for Stem Cell Biology and Regenerative Medicine: Major US academic stem cell and regenerative medicine institute. Comparable research scope spanning hematopoiesis, developmental biology, and cancer, with significantly larger funding base and industry partnerships.
• Whitehead Institute for Biomedical Research: MIT-affiliated independent biomedical research institute with programs in stem cells, cancer biology, developmental biology, and imaging. Comparable blend of fundamental life sciences research with strong publication output.
• Harvard Department of Stem Cell and Regenerative Biology: Harvard Medical School department covering stem cell biology, developmental biology, and regenerative medicine. Strongly comparable research themes including hematopoiesis and epigenetics, though operating at elite US-academic scale.
• Wellcome-MRC Cambridge Stem Cell Institute: Large UK-based stem cell research institute with broad programs across hematopoietic, pluripotent, and epithelial stem cells. Comparable in basic research mission, with much larger scale and funding.

Direct peers

• Tokyo Metropolitan Institute of Medical Science: Public medical research institute in Tokyo with overlapping hematopoiesis, stem cell, and cancer biology research. Recently hired IRCMS Vice Director Goro Sashida, evidencing direct research overlap.
• Institute of Medical Science, University of Tokyo (IMSUT): Japan-based academic life sciences and medical research institute with overlapping focus areas in hematological malignancies and infectious disease. Already an active IRCMS collaboration partner via the JSPS Core-to-Core Program.
• Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University: Same-campus Kumamoto University institute focused on molecular embryology and developmental genetics. Shares infrastructure and research themes with IRCMS, particularly in developmental biology and morphogenesis.
• Lund University Stem Cell Center: Swedish stem cell research center with deep focus on hematopoietic stem cells and leukemic stem cells. Active IRCMS partner under the JSPS Core-to-Core Program, with regular Lund-Kumamoto Hematopoiesis joint meetings.
• Center for iPS Cell Research and Application (CiRA), Kyoto University: Kyoto University's flagship iPS/stem cell research center in Japan. Directly comparable to IRCMS in mission (basic-to-translational stem cell biology, developmental biology, hematopoiesis) and academic structure, though at substantially larger scale with more direct industry ties.
• RIKEN Center for Life Science Technologies: Major Japanese national research institute conducting fundamental research in life sciences including stem cells, developmental biology, and medical imaging. Comparable in its blend of basic life science research and technology development.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/IRCMS_KU
• YouTubeyoutube.com/channel/UC2AaBlubZfGHXNqTFreQCyw
• Facebookfacebook.com/IRCMS-International-Research-Center-for-Medical-Sciences-107782423019645
• LinkedInlinkedin.com/company/ircms-kumamoto-university
• Instagraminstagram.com/ircms_ku

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IRCMS, Kumamoto University